Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors

被引:14
作者
Calugi, Chiara [1 ]
Guarna, Antonio [1 ]
Trabocchi, Andrea [1 ]
机构
[1] Univ Florence, Dept Chem Ugo Schiff, I-50019 Florence, Italy
关键词
Molecular docking; peptidomimetic; virulence factor; infectious disease; aspartic protease; IMMUNODEFICIENCY-VIRUS PROTEASE; IN-VITRO; PROTEINASE-INHIBITORS; VIRULENCE PROPERTIES; INFECTED PATIENTS; CRYSTAL-STRUCTURE; POTENT INHIBITOR; EXPRESSION; DOCKING; DESIGN;
D O I
10.3109/14756366.2012.696245
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The analysis of the structural similarity between Candida albicans Sap2 and HIV-1 aspartic proteases by molecular modeling gave insight into the common requirements for inhibition of both targets. Structure superimposition of Sap2 and HIV-1 protease confirmed the similarity between their active sites and flap regions. HIV-1 protease inhibitors herein investigated can fit the active site of Sap2, adopting very similar ligand-backbone conformations. In particular, key anchoring sites consisting of Gly85 in Sap2 and Ile50 in HIV-1 protease, both belonging to their corresponding flap regions, were found as elements of a similar binding-mode interaction. The knowledge of the molecular basis for binding to both Sap2 and HIV-1 proteases may ultimately lead to the development of single inhibitor acting on both targets.
引用
收藏
页码:936 / 943
页数:8
相关论文
共 34 条
[1]  
AbadZapatero C, 1996, PROTEIN SCI, V5, P640
[2]   Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions [J].
Albrecht, A ;
Felk, A ;
Pichova, I ;
Naglik, JR ;
Schaller, M ;
de Groot, P ;
MacCallum, D ;
Odds, FC ;
Schäfer, W ;
Klis, F ;
Monod, M ;
Hube, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :688-694
[3]  
[Anonymous], PYMOL MOL GRAPHICS S
[4]   Experimental and Computational Active Site Mapping as a Starting Point to Fragment-Based Lead Discovery [J].
Behnen, Juergen ;
Koester, Helene ;
Neudert, Gerd ;
Craan, Tobias ;
Heine, Andreas ;
Klebe, Gerhard .
CHEMMEDCHEM, 2012, 7 (02) :248-261
[5]   THE 3-D STRUCTURE OF HIV-1 PROTEINASE AND THE DESIGN OF ANTIVIRAL AGENTS FOR THE TREATMENT OF AIDS [J].
BLUNDELL, TL ;
LAPATTO, R ;
WILDERSPIN, AF ;
HEMMINGS, AM ;
HOBART, PM ;
DANLEY, DE ;
WHITTLE, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (11) :425-430
[6]   HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases [J].
Borg-von Zepelin, M ;
Meyer, I ;
Thomssen, R ;
Würzner, R ;
Sanglard, D ;
Telenti, A ;
Monod, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :747-751
[7]   In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors [J].
Cassone, A ;
De Bernardis, F ;
Torosantucci, A ;
Tacconelli, E ;
Tumbarello, M ;
Cauda, R .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :448-453
[8]   EVIDENCE FOR A CORRELATION BETWEEN PROTEINASE SECRETION AND VULVO-VAGINAL CANDIDOSIS [J].
CASSONE, A ;
DEBERNARDIS, F ;
MONDELLO, F ;
CEDDIA, T ;
AGATENSI, L .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (05) :777-783
[9]  
Cataldo M, 2003, TRENDS IN MEDICAL MYCOLOGY, P165
[10]   THE CRYSTAL-STRUCTURE OF A MAJOR SECRETED ASPARTIC PROTEINASE FROM CANDIDA-ALBICANS IN COMPLEXES WITH 2 INHIBITORS [J].
CUTFIELD, SM ;
DODSON, EJ ;
ANDERSON, BF ;
MOODY, PCE ;
MARSHALL, CJ ;
SULLIVAN, PA ;
CUTFIELD, JF .
STRUCTURE, 1995, 3 (11) :1261-1271